India To Actively Participate In COVID-19 Vaccine Development
Serum Institute of India is preparing to dole out a billion doses.
As has been said by Indian Prime Minister Narendra Modi, India is all set to actively participate in the development and distribution of the all-elusive COVID-19 vaccine. “Today also our companies are active in international efforts for development and production of COVID-19 vaccine,” PM Modi had said back in July. The Pune-based firm, Serum Institute of India, which is the world’s largest vaccine manufacturer by volume, is expected to start trials of the Oxford/AstraZeneca COVID-19 vaccine candidate in India soon.
The Serum Institute of India will be working in partnership with the Indian Council of Medical Research (ICMR). It has been said that by the end of August 2020, between 4,000 to 5,000 people residing in Pune and Mumbai will be injected with the vaccine as part of trials scheduled to last over two months. The Serum Institute has also revealed that it plans to manufacture 300 million to 400 million doses of the vaccine by the end of the year.
Get the latest COVID-19 updates only on ZEE5.